Nuvation Bio (NUVB) Return on Sales (2024 - 2026)

Nuvation Bio (NUVB) posted quarterly Return on Sales of 0.0% for Q1 2026, up 17.0% year-over-year from 0.0% in Q1 2025, and up 107.42% quarter-over-quarter from 0.01% in Q4 2025.

Nuvation Bio (NUVB) Return on Sales (2024 - 2026) Analysis & Trends

Nuvation Bio (NUVB) has reported Return on Sales for 3 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Return on Sales rose 17.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (up 54.0% YoY), while the FY2025 annual figure was 0.03%, up 69.0% from the prior year.
  • Return on Sales grew to 0.0% in Q1 2026 per NUVB's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q1 2026 and bottomed at 3.22% in Q2 2024.
  • Historically, Return on Sales has averaged 0.53% across 3 years, with a median of 0.1% in 2024.
  • On a YoY basis, Return on Sales climbed as much as 310 bps in 2025 and fell as far as 8 bps in 2025.
  • Nuvation Bio's Return on Sales stood at 0.09% in 2024, then soared by 90 bps to 0.01% in 2025, then soared by 107 bps to 0.0% in 2026.
  • Business Quant data shows NUVB's Return on Sales at 0.0% in Q1 2026, 0.01% in Q4 2025, and 0.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Nuvation Bio 2.16 Bn 2.16 Bn 30.78 Mn -0.02%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.02%
Mar 31, 2026 0.00%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.04%
Jun 30, 2025 -0.12%
Mar 31, 2025 -0.17%
Dec 31, 2024 -0.09%
Sep 30, 2024 -0.57%
Jun 30, 2024 -3.22%